GREY — Grey Matters Health Share Price
0.000.00%
Last trade - 00:00- CA$2.17m
- CA$1.97m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 0.93 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -83.94% | ||
| Return on Equity | -106.45% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Aug | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | 1.5 | 61.5 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Grey Matters Health Inc, formerly Algernon Health Inc., is a Canadian healthcare company. The Company is focused on the provision of brain-specific PET scanning services through a planned network of new clinics in North America for the early-stage detection of Alzheimer’s disease, as well as other forms of dementia, epilepsy, neuro-oncology, and movement disorders. It is also the parent company of a private subsidiary called Algernon NeuroScience that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury recovery. The Company also owns a 20% equity position in Seyltx, a private U.S-based drug development company advancing a chronic cough drug called Ifenprodil.
Directors
- Last Annual
- August 31st, 2025
- Last Interim
- February 28th, 2026
- Incorporated
- April 10th, 2015
- Public Since
- February 1st, 2016
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 5,418,243
- Address
- Suite 400 - 601 West Broadway, VANCOUVER, V5Z 4C2
- Web
- https://algernonpharmaceuticals.com
- Phone
- +1 6043984175
- Contact
- Christopher Moreau
- Auditors
- Smythe LLP
Upcoming Events for GREY
Grey Matters Health Inc Annual Shareholders Meeting
Q4 2026 Grey Matters Health Inc Earnings Release
Similar to GREY
Albert Labs International
Canadian Securities Exchange
Asep Medical Holdings
Canadian Securities Exchange
BetterLife Pharma
Canadian Securities Exchange
BioMark Diagnostics
Canadian Securities Exchange
Biovaxys Technology
Canadian Securities Exchange
FAQ
What is the Grey Matters Health share price?
As of Today at 11:58 UTC, shares in Grey Matters Health are trading at CA$0.40. This share price information is delayed by 15 minutes.
How has the Grey Matters Health share price performed this year?
Shares in Grey Matters Health last closed at CA$0.40 and the price had moved by -55.56% over the past 365 days. In terms of relative price strength the Grey Matters Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -66.63% over the past year.
What are the analyst and broker recommendations for Grey Matters Health?
The overall consensus recommendation for Grey Matters Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Grey Matters Health dividend yield?
Grey Matters Health does not currently pay a dividend.
Does Grey Matters Health pay a dividend?
Grey Matters Health does not currently pay a dividend.
When does Grey Matters Health next pay dividends?
Grey Matters Health does not currently pay a dividend.
How do I buy Grey Matters Health shares?
To buy shares in Grey Matters Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Grey Matters Health?
As of the previous close price of CA$0.40, shares in Grey Matters Health had a market capitalisation of CA$2.17m.
Where are Grey Matters Health shares listed?
Here are the trading details for Grey Matters Health:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: GREY
What kind of share is Grey Matters Health?
Based on an overall assessment of its quality, value and momentum Grey Matters Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Grey Matters Health share price forecast for 2026?
The analyst consensus target price for shares in Grey Matters Health is CA$2.56. That is 540% above the last closing price of CA$0.40.
Analysts covering Grey Matters Health currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.57 for the next financial year.
Find out moreWhat is the trend in the Grey Matters Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Grey Matters Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -55.61%.
As of the last closing price of CA$0.40, shares in Grey Matters Health were trading -36.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Grey Matters Health PE Ratio?
The Grey Matters Health PE ratio based on its reported earnings over the past 12 months is 0.93. The shares last closed at CA$0.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Grey Matters Health?
We do not have data on Grey Matters Health's directors